Paul Tudor Jones’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Paul Tudor Jones’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,000	Closed	-$197K	–	1456
2019 Q4	$197K	Buy	+10,000	New	+$160K	0.01%	996
2017 Q2	–	Sell	-19,100	Closed	-$255K	–	1500
2017 Q1	$255K	Sell	19,100 -4,029	-17%	-$63.1K	0.01%	1098
2016 Q4	$348K	Buy	23,129 +3,398	+17%	+$44.9K	0.01%	937
2016 Q3	$231K	Buy	+19,731	New	+$232K	0.01%	1180
2015 Q4	–	Sell	-19,347	Closed	-$317K	–	1919
2015 Q3	$317K	Buy	19,347 +3,415	+21%	+$69.9K	0.01%	1067
2015 Q2	$363K	Buy	+15,932	New	+$317K	0.01%	990
2014 Q2	–	Sell	-29,800	Closed	-$347K	–	1395
2014 Q1	$347K	Buy	+29,800	New	+$505K	0.01%	727
2013 Q4	–	Sell	-10,600	Closed	-$153K	–	1394
2013 Q3	$153K	Buy	+10,600	New	+$162K	0.01%	759

Other funds holding MNTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Paul Tudor Jones's MNTA Position: Q1 2020 in Review

Paul Tudor Jones sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2020, closing a stake of 10,000 shares — an estimated $197K sold.

Paul Tudor Jones first reported a position in MNTA in Q3 2013 and held it in 8 quarters. The position peaked at $363K in Q2 2015. 199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

Paul Tudor Jones reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Paul Tudor Jones sold 10,000 Momenta Pharmaceuticals, Inc. shares in Q1 2020, an estimated $197K.
Paul Tudor Jones first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 8 quarters.
Paul Tudor Jones's Momenta Pharmaceuticals, Inc. position peaked at $363K in Q2 2015.
199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.